Extraamniotic prostaglandin F2α for intrauterine death and fetal abnormality

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 7, Issue 5, 1977, Pages 325-329

  Luengo, J ^a   Keirse, M J N C ^a   Bennebroek Gravenhorst, J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

fetal death; missed abortion; prostaglandin; stillbirth; termination of pregnancy

Indexed keywords

ABORTIVE AGENT; PROSTAGLANDIN F; PROSTAGLANDIN F2 ALPHA; VACCINE;

ABORTION, DRUG INDUCED; ARTICLE; BIOLOGY; CONGENITAL ABNORMALITIES; CONGENITAL MALFORMATION; DEMOGRAPHIC FACTORS; DISEASES; ENDOCRINE SYSTEM; EVALUATION; FAMILY PLANNING; FEMALE; FERTILITY CONTROL, POSTCONCEPTION; FETUS DEATH; HUMAN; INDUCED ABORTION; LABOR INDUCTION; MORTALITY; NEWBORN DISEASE; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PREGNANCY; PREGNANCY COMPLICATION; PROSTAGLANDINS--SIDE EFFECTS; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; ADVERSE DRUG REACTION; CONGENITAL DISORDER; DELIVERY; DIAGNOSIS; DRUG ADMINISTRATION; FATALITY; HYDATIDIFORM MOLE; NAUSEA; PREGNANCY TERMINATION; THERAPY; VOMITING;

ABORTIFACIENT AGENTS; ABORTION, DRUG INDUCED; ABORTION, INDUCED; BIOLOGY; CONGENITAL ABNORMALITIES; DEMOGRAPHIC FACTORS; DISEASES; ENDOCRINE SYSTEM; EVALUATION; FAMILY PLANNING; FERTILITY CONTROL, POSTCONCEPTION; FETAL DEATH; MORTALITY; NEONATAL DISEASES AND ABNORMALITIES; PHYSIOLOGY; POPULATION; POPULATION DYNAMICS; PREGNANCY COMPLICATIONS; PROSTAGLANDINS--SIDE EFFECTS;

ABNORMALITIES; ABORTION, INDUCED; DINOPROST; FEMALE; FETAL DEATH; HUMAN; LABOR, INDUCED; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROSTAGLANDINS F;

EID: 0017624198     PISSN: 00282243     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-2243(77)90017-X     Document Type: Article

References (16)

1. Rapid reduction of prostaglandin 15-hydroxy-dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors
2. Interaction of E prostaglandins and Syntocinon on the pregnant human myometrium
3. The use of prostaglandins for therapeutic termination of pregnancy
4. 2α
5. Extra amniotic prostaglandins in the management of intra-uterine fetal death, anencephaly and hydatidiform mole
6. 2 in the management of intra-uterine death, missed abortion and hydatidiform mole
7. Prostaglandin-oxytocin enhancement and potentiation and their clinical applications
8. 2 in the management of missed abortion, missed labour, and hydatidi- form mole
9. Interruption of pregnancy with prostaglandins
10. Studies on prostaglandins in relation to human parturition
11. Metabolism of prostaglandins within the pregnant uterus
12. 2α within the human uterus in early pregnancy
13. Hormonal interactions in the mechanism of parturition
14. Single extraamniotic injection of prostaglandins in viscous gel to induce abortion
15. The use of prostaglandins for missed abortion, fetal death in utero and hydatidiform mole
16. Induction of labour with prostaglandins